• Mutation; HGNC; HGNC:1833; CEBPA; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000851673; Zygosity=Heterozygous (PubMed=29955132).
  
• Mutation; HGNC; HGNC:4768; H3C3; Simple; p.Lys28Met (c.83A>T); Zygosity=Heterozygous (PubMed=29955132).
  
• Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000219097; Zygosity=Heterozygous (PubMed=29955132).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29955132).
  

PubMed=11108571; DOI=10.1080/13684730050515787
Satoki Nakamura, Kazunori Ohnishi, Hitoshi Yoshida, Kaori Shinjo, Akihiro Takeshita, Kaoru Tohyama, Ryuzo Ohno, Yukio Koide;
Retrovirus-mediated gene transfer of granulocyte colony-stimulating factor receptor (G-CSFR) cDNA into MDS cells and induction of their differentiation by G-CSF.
Cytokines Cell. Mol. Ther. 6:61-70(2000)

PubMed=20130600; DOI=10.1038/leu.2009.296
Atsuko Matsuoka, Aki Tochigi, Michimasa Kishimoto, Takako Nakahara, Toshinori Kondo, Takayuki Tsujioka, Taizo Tasaka, Yumi Tohyama, Kaoru Tohyama;
Lenalidomide induces cell death in an MDS-derived cell line with deletion of chromosome 5q by inhibition of cytokinesis.
Leukemia 24:748-755(2010)

PubMed=29955132; DOI=10.1038/s41375-018-0189-7
Jun-ichiro Kida, Takayuki Tsujioka, Shin-ichiro Suemori, Shuichiro Okamoto, Kanae Sakakibara, Takayuki Takahata, Takahiro Yamauchi, Akira Kitanaka, Yumi Tohyama, Kaoru Tohyama;
An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS.
Leukemia 32:1846-1850(2018)